pneumonia
common
affect
adult
uk
year
although
patient
pneumonia
make
complet
recoveri
antibiot
support
care
pneumonia
remain
common
caus
death
mortal
among
adult
admit
hospit
pneumonia
approxim
around
half
death
occur
patient
age
year
older
pneumonia
classifi
accord
locat
circumst
develop
distinguish
communityacquir
pneumonia
cap
hospitalacquir
pneumonia
hap
aspir
pneumonia
pneumonia
immunocompromis
host
within
categori
hap
known
ventilatorassoci
pneumonia
vap
pneumonia
aris
de
novo
intub
mechan
ventil
patient
pragmat
classif
indic
like
rang
caus
pathogen
thu
guid
empir
antibiot
therapi
classif
system
help
guid
treatment
confus
aspect
terminolog
arisen
worth
consid
particular
strictli
speak
aspir
pneumon
chemic
injuri
induc
noninfect
liquid
enter
lung
exampl
gastric
acid
patient
whose
consciou
level
deterior
rapidli
perhap
due
alcohol
intox
protect
hisher
airway
vomit
scenario
usual
wit
aspir
moder
volum
aspir
pneumonia
entail
repeat
clinic
silent
usual
unwit
entri
small
volum
infect
materi
lung
usual
oropharynx
patient
chronic
impair
swallow
andor
conscious
exampl
patient
neurolog
condit
stroke
motor
neuron
diseas
multipl
sclerosi
distinct
import
least
initi
aspir
pneumon
requir
antibiot
treatment
unfortun
two
term
often
use
interchang
situat
confus
true
bacteri
pneumonia
complic
aspir
pneumon
day
initi
aspir
similarli
reader
may
encount
term
healthcareassoci
pneumonia
hcap
seek
distinguish
hap
pneumonia
acquir
healthcar
organis
hospit
eg
nurs
home
rang
organ
implic
suffici
differ
us
make
distinct
final
vap
becom
increasingli
use
marker
healthcar
standard
bewild
confus
array
new
term
eg
ventilatorassoci
event
ventilatorassoci
condit
infect
p
hellyer
j
rostron
j
simpson
institut
cellular
medicin
newcastl
univers
newcastl
upon
tyne
uk
email
tphellyer
nclacuk
ventilatorassoci
condit
emerg
key
point
term
employ
aid
epidemiolog
surveil
term
use
make
diagnos
real
time
therefor
appear
chapter
recent
year
excel
comprehens
guidelin
publish
manag
communityacquir
pneumonia
cap
adult
key
recommend
guidelin
readili
access
firmli
embed
knowledg
base
medic
commun
chapter
focu
adult
pneumonia
good
guidelin
childhood
pneumonia
found
elsewher
parapneumon
effus
empyema
import
complic
pneumonia
consid
briefli
chapter
greater
detail
found
chapter
pleural
diseas
consid
pneumonia
detail
also
worth
reflect
john
bunyan
identif
seventeenth
centuri
tuberculosi
captain
men
death
remain
pertin
today
therefor
histor
resili
import
global
caus
pneumonia
deserv
chapter
strictest
patholog
sens
pneumonia
defin
inflamm
ga
exchang
region
lung
infect
commonest
caus
alveolar
inflamm
pneumonia
regard
infect
inflamm
alveolar
region
worth
note
howev
strict
definit
pneumonia
lead
sometim
confusingli
term
like
usual
interstiti
pneumonia
uip
nonspecif
interstiti
pneumonia
nsip
interstiti
lung
diseas
literatur
characteris
inflammatori
infiltr
alveolar
wall
true
patholog
sens
pneumonia
gener
believ
pathogen
bacteria
evad
multitud
innat
immun
defenc
conduct
airway
alveolar
macrophag
am
capabl
remov
lowlevel
alveolar
inocul
occasion
defenc
overwhelm
am
signal
recruit
alveolu
cellular
inflammatori
exud
predominantli
compos
neutrophil
neutrophil
avidli
phagocyt
cell
recruit
engag
ingest
kill
bacteria
bacteria
packag
phagolysosom
insid
neutrophil
within
reactiv
oxygen
speci
high
concentr
proteolyt
enzym
gener
lead
bacteri
death
gener
believ
cytokin
gener
local
system
recruit
neutrophil
contribut
fever
malais
loss
appetit
weight
loss
confus
delirium
experienc
patient
sever
pneumonia
signific
contribut
lung
destruct
may
come
toxic
content
neutrophil
spill
extracellularli
attack
host
although
may
contribut
bacteri
virul
factor
also
battl
bacteria
neutrophil
alveolar
space
becom
pack
neutrophil
exud
consolid
alveolar
wall
expand
engorg
capillari
involv
alveolu
therefor
effect
contribut
shunt
perfus
ventil
dyspnoea
ultim
hypoxaemia
ensu
suffici
alveoli
involv
adjac
bronchi
involv
enough
alveolar
tissu
consolid
chest
xray
cxr
ct
scan
often
reveal
classic
air
bronchogram
fig
similarli
air
flow
bronchu
unimped
pneumonia
breath
sound
distort
amplifi
consolid
alveoli
lead
bronchial
breath
auscult
whisper
pectoriloquy
practic
howev
pneumonia
commonli
patchi
process
fig
left
panel
foci
infect
alveoli
rather
one
larg
contigu
area
consolid
therefor
inspiratori
crackl
inspir
air
open
partli
consolid
alveoli
far
common
auscultatori
find
bronchial
breath
rel
rare
present
lobar
pneumonia
still
provid
valuabl
clinic
inform
almost
alway
caus
streptococcu
pneumonia
far
less
commonli
klebsiella
pneumonia
usual
expand
consolid
right
upper
lobe
much
understand
macroscop
patholog
pneumonia
deriv
postmortem
specimen
lobar
pneumonia
preantibiot
era
classic
studi
describ
congest
phase
quickli
follow
red
hepatis
lobe
appear
macroscop
like
liver
cut
section
alveolar
wall
expand
capillari
engorg
erythrocyt
mani
spill
alveolu
neutrophil
alveolar
space
fill
exud
capillari
fig
right
panel
exud
fluid
rich
plasma
protein
includ
fibrinogen
fibrin
strand
form
alveolu
may
serv
limit
spread
infect
localis
bacteria
area
host
defenc
concentr
provid
scaffold
alveolar
repair
howev
excess
fibrin
reaction
sever
pneumonia
may
potenti
lead
fibrot
scar
format
strike
find
pneumonia
particularli
lobar
pneumonia
process
complet
resolv
restor
entir
normal
alveolar
architectur
inde
featur
histolog
pneumonia
alveolar
wall
lefthand
panel
lowpow
histolog
section
lung
stain
haematoxylin
eosin
h
e
dens
pink
area
show
pneumonia
characterist
patchi
distribut
righthand
panel
show
histolog
section
stain
h
e
demonstr
pneumonia
green
arrow
point
collect
neutrophil
alveolar
space
orang
arrow
point
white
area
would
fill
proteinrich
liquid
exud
fill
alveolu
blue
arrow
point
ghostli
outlin
alveolar
capillari
alveolar
wall
significantli
engorg
promin
red
blood
cell
recognis
consolid
shown
right
hand
panel
fig
remark
feat
resolut
recognis
long
widespread
use
antibiot
process
seem
characteris
care
regul
process
depend
neutrophil
clear
bacteria
effici
undergo
apoptosi
program
cell
death
without
disgorg
toxic
content
macrophag
ingest
erythrocyt
apoptot
neutrophil
well
scaveng
extracellular
debri
migrat
region
lymph
node
sequenc
explain
classic
macroscop
phase
white
hepatis
capillari
becom
less
engorg
macrophag
predomin
erythrocyt
neutrophil
stillpack
alveoli
bacteri
kill
neutrophil
produc
myeloperoxidas
impart
green
colour
sputum
patchi
pneumonia
rare
imping
pleura
pneumonia
caus
pain
inflamm
involv
pleura
pain
pneumonia
almost
alway
pleurit
natur
pleural
involv
commonli
result
effus
infect
penetr
alveolar
space
pleural
space
may
lead
empyema
inflamm
diaphragmat
pleura
especi
right
caus
pain
refer
right
iliac
fossa
mimic
append
caus
death
pneumonia
usual
progress
septic
shock
andor
progress
acut
respiratori
distress
syndrom
rare
aggress
lung
necrosi
may
complic
pneumonia
exampl
pneumonia
caus
staphylococcu
aureu
produc
pantonvalentin
leukocidin
pvl
virul
factor
pneumonia
associ
cardiovascular
complic
may
account
earli
death
also
potenti
observ
mortal
increas
year
follow
appar
good
recoveri
pneumonia
grow
literatur
characteris
featur
cap
requir
admiss
intens
care
unit
perhap
surprisingli
sever
ill
admiss
bilater
pulmonari
infiltr
ventil
support
independ
associ
increas
mortal
sever
pneumonia
common
patient
comorbid
postantibiot
era
initi
present
lung
abscess
uncommon
common
homeless
patient
patient
alcohol
depend
perhap
combin
poor
dental
hygien
increas
rate
haematogen
bacteraemia
inadequ
nutrit
late
present
rel
immunosuppress
failur
consolid
alveoli
reaerat
pneumonia
may
leav
minor
atelectasi
seen
fine
linear
scar
cxr
sever
pneumonia
lead
necrosi
andor
acut
respiratori
distress
syndrom
ard
commonli
accompani
widespread
scar
may
produc
restrict
ventilatori
defect
detect
lung
function
test
practic
term
common
complic
consid
pleural
effus
separ
chapter
pleural
diseas
provid
greater
detail
briefli
pleural
effus
frequent
accompani
pneumonia
frequenc
estim
vari
wide
gener
around
onethird
patient
hospitalis
pneumonia
evid
associ
pleural
effus
effus
divid
parapneumon
effus
pleura
produc
reactiv
exud
respons
inflamm
pleural
space
infect
empyema
pleural
space
infect
parapneumon
effus
usual
resorb
resolv
spontan
clearanc
pneumonia
scar
rare
howev
effus
occasion
larg
may
compress
effect
adjac
consolid
lung
ad
breathless
empyema
complic
approxim
pneumonia
manag
hospit
far
seriou
consequ
bacteria
may
identifi
gram
stain
via
cultur
absenc
identifi
pathogen
exclud
empyema
clinic
biochem
featur
support
diagnosi
importantli
fibrinogen
rapidli
convert
insolubl
fibrin
usual
lead
wall
locul
pu
pleural
space
longer
singl
drainabl
collect
multipl
small
unconnect
collect
fig
empyema
becom
locul
wall
chronic
pocket
infect
consum
enorm
amount
energi
caus
pain
make
chest
drain
insert
futil
one
tube
drain
one
singl
locul
preantibiot
era
empyema
well
recognis
form
pain
sinus
skin
though
rare
characterist
describ
dictat
manag
effus
associ
pneumonia
suffici
fluid
aspir
easili
safe
ultrasound
guidanc
ml
sampl
suffici
test
ph
protein
lactat
dehydrogenas
differenti
white
cell
count
gram
stain
bacteri
cultur
light
criteria
use
determin
exud
transud
latter
associ
pneumonia
gross
appear
ph
ldh
differenti
count
microbiolog
help
distinguish
empyema
parapneumon
effus
ultrasound
determin
whether
locul
start
normal
left
lung
empyema
dark
grey
multipl
black
airfil
locul
transvers
ct
scan
show
dens
effus
right
lower
thorax
aspir
reveal
pu
aspir
materi
low
ph
low
glucos
high
ldh
concentr
multipl
black
hole
dens
effus
impli
airfil
pocket
implic
empyema
becom
complic
fibrin
strand
wall
separ
collect
lower
panel
show
thoracoscop
appear
subacut
empyema
imag
courtesi
mr
malcolm
small
parapneumon
effus
usual
requir
drainag
larg
parapneumon
effus
caus
breathless
usual
manag
intercost
drain
empyema
locul
must
drain
intercost
tube
prompt
pleural
drainag
prevent
complic
empyema
empyema
complic
develop
locul
may
requir
surgic
intervent
order
break
fibrin
band
creat
one
collect
drain
clearli
recommend
context
pneumonia
also
manag
antibiot
measur
detail
cap
estim
incid
per
popul
western
countri
though
figur
hide
skew
toward
increas
incid
age
approxim
quarter
patient
requir
hospit
inhospit
mortal
approxim
figur
describ
reflect
adult
popul
west
simpli
aim
give
sens
magnitud
problem
import
asid
semin
paper
black
et
al
recommend
reader
describ
five
million
death
annual
age
five
chart
global
distribut
good
evid
subsequ
work
problem
persist
major
death
pneumonia
combin
pneumonia
gastroenter
death
pneumonia
children
adult
admit
hospit
remain
rare
west
cap
far
predomin
pathogen
streptococcu
pneumonia
account
case
pneumonia
gramposit
coccu
thick
capsul
decor
antigen
distinguish
differ
serotyp
antigen
lend
develop
vaccin
diagnost
test
betalactam
ring
penicillin
bind
inhibit
crosslink
peptidoglycan
process
crucial
cell
wall
format
bacteria
pneumonia
domin
place
pneumonia
produc
cap
fact
rarer
pathogen
caus
cap
suscept
penicillin
explain
penicillin
amoxicillin
core
cap
treatment
howev
three
set
organ
requir
special
attent
context
soon
widespread
use
penicillin
dramat
reduc
mortal
cap
becam
appar
form
cap
atyp
suscept
penicillin
gener
occur
younger
patient
tendenc
extrapulmonari
manifest
alongsid
pneumonia
pathogen
respons
atyp
pneumonia
soon
characteris
cell
wall
henc
inher
resist
penicillin
includ
mycoplasma
pneumonia
coxiella
burnetii
chlamydophila
pneumonia
chlamydophila
psittaci
gener
caus
selflimit
infect
produc
sever
pneumonia
major
concern
group
relat
legionella
pneumophila
caus
sever
lifethreaten
pneumonia
rang
extrapulmonari
manifest
includ
cardiac
neurolog
renal
diseas
diarrhoea
hyponatraemia
hypophosphataemia
muscl
pain
high
serum
creatin
kinas
legionnair
diseas
transmit
droplet
contamin
water
cool
tower
air
condit
system
focu
highprofil
outbreak
public
health
investig
l
pneumophila
caus
moder
sever
pneumonia
guidelin
recommend
macrolid
ad
penicillin
scenario
second
import
caveat
relat
influenza
influenza
pandem
mortal
cap
increas
dramat
seen
infam
outbreak
thought
kill
peopl
world
war
combin
patient
undoubtedli
die
influenza
pneumonia
equal
doubt
influenza
increas
suscept
secondari
bacteri
pneumonia
lead
third
caveat
surround
staphylococcu
aureu
incid
sever
aureu
pneumonia
markedli
increas
influenza
pandem
aureu
pneumonia
carri
high
mortal
almost
uk
strain
produc
penicillinas
consequ
sever
cap
acquir
influenza
season
flucloxacillin
penicillinaseresist
penicillin
prescrib
common
misconcept
aureu
pathogen
complic
influenza
pneumonia
behav
aggress
influenza
haemophilu
influenza
usual
associ
mild
cap
caus
sever
pneumonia
secondari
influenza
pneumonia
caus
sever
pneumonia
respons
cap
surpris
pneumonia
consist
found
organ
associ
sever
pneumonia
icu
seri
collect
observ
explain
mild
cap
treat
amoxicillin
moder
sever
cap
amoxicillin
macrolid
flucloxacillin
ad
influenza
outbreak
combin
cover
pathogen
time
occasion
clinic
clue
suggest
specif
pathogen
rare
pathognomon
discuss
earlier
right
upper
lobe
pneumonia
lobar
expans
suggest
pneumonia
k
pneumonia
cavit
suggest
aureu
k
pneumonia
tuberculosi
presenc
chronic
obstruct
pulmonari
diseas
copd
increas
likelihood
h
influenza
pneumonia
though
pneumonia
remain
commonest
pathogen
cap
secondari
copd
case
pneumonia
patient
copd
may
caus
moraxella
catarrhali
produc
betalactamas
resist
amoxicillin
pseudomona
aeruginosa
also
resist
penicillin
return
foreign
travel
pneumonia
rais
possibl
legionnair
diseas
especi
stay
hotel
air
condit
system
warm
countri
particular
pneumonia
associ
particular
geograph
locat
exampl
melioidosi
south
east
asia
northern
australia
middl
east
respiratori
syndrom
coronaviru
merscov
outbreak
hap
defin
new
pneumonia
aris
two
day
admiss
hospit
evolv
commun
prior
admiss
estim
preval
hap
around
patient
hap
suspect
elderli
frail
differenti
true
hap
rang
hospitalacquir
thorac
patholog
difficult
obtain
microbiolog
sampl
alveolar
region
harder
stillbronchoalveolar
lavag
bal
rare
justifi
like
toler
goodqual
sputum
sampl
reflect
alveolar
region
rare
antibiot
frequent
start
empir
hap
occur
first
week
hospit
admiss
like
caus
pneumonia
aureu
h
influenza
coliform
pass
time
rang
potenti
pathogen
becom
wider
greater
represent
virul
antibioticresist
pathogen
vap
new
pneumonia
aris
least
h
intub
mechan
ventil
although
estim
vari
consider
vap
appear
occur
intub
mechan
ventil
patient
crude
mortal
rate
around
though
attribut
mortal
patient
icu
equival
sever
ill
without
pneumonia
far
smaller
contrast
cap
quit
differ
set
pathogen
implic
hap
vap
bestcharacteris
form
hap
vap
occur
earli
intens
care
unit
icu
stay
like
caus
organ
pneumonia
methicillinsensit
aureu
h
influenza
gramneg
bacilli
howev
lateonset
vap
day
caus
plethora
organ
gener
virul
like
antibioticresist
gramneg
bacilli
includ
p
aeruginosa
bacteria
enterobacteriacea
famili
gramposit
aureu
domin
pathogen
empir
therapi
lateonset
vap
take
account
vital
good
microbiolog
surveil
epidemiolog
hospit
know
like
pathogen
institut
microbiolog
epidemiolog
hap
vap
vari
consider
hospit
often
differ
unit
within
hospit
bacteri
aetiolog
aspir
pneumonia
less
well
understood
wide
held
belief
anaerob
bacteria
disproportion
repres
aspir
pneumonia
studi
implic
gramneg
coliform
part
problem
studi
aspir
pneumonia
relat
practic
difficulti
obtain
highqual
repres
alveolar
sampl
patient
suspect
aspir
pneumonia
often
frail
cough
well
enough
produc
adequ
sputum
sampl
may
sputum
product
may
unwel
bronchoscopi
central
pathophysiolog
pneumonia
bacteri
inoculum
reach
lung
import
lower
respiratori
tract
infect
tuberculosi
influenza
legionnair
diseas
undoubtedli
acquir
direct
inhal
airborn
droplet
contrast
seem
like
vap
caus
microaspir
small
volum
inocula
colonis
oropharynx
support
effect
subglott
suction
drainag
remov
potenti
infect
secret
sit
cuff
endotrach
tube
associ
significantli
reduc
vap
close
correl
colonis
oropharyng
bacteria
pathogen
later
isol
pneumon
lung
regard
aspir
pneumonia
wit
largevolum
aspir
rel
rare
occurr
far
common
repeat
lowvolum
aspir
elderli
patient
reduc
consciou
level
andor
impair
laryng
protect
reflex
therefor
like
aspir
pneumonia
follow
pathogenesi
vap
alter
colonis
profil
emerg
oropharynx
hospit
nurs
home
environ
repeat
aspir
small
inocula
lung
rout
inocul
direct
dropletaerosol
inhal
microaspir
predominantli
respons
cap
caus
pneumonia
harder
determin
colonis
oropharynx
pneumonia
rel
common
healthi
popul
higher
hospitalis
cohort
known
high
frequenc
microaspir
howev
aerosol
spread
pneumonia
well
known
occur
therefor
fairli
persuas
evid
pneumonia
reach
alveolar
space
either
rout
situat
may
well
appli
pathogen
implic
cap
face
patient
possibl
pneumonia
import
determin
pneumonia
like
diagnosi
clinic
ground
like
organ
mani
ill
mimic
pneumonia
tabl
diagnosi
alway
straightforward
furthermor
gold
standard
diagnosi
pneumonia
use
histolog
cultur
lung
biopsi
materi
confirm
infect
inflam
alveolar
tissu
unachiev
undesir
patient
surrog
clinic
tool
diagnosi
inadequ
difficulti
diagnosi
tend
encourag
overus
antibiot
clinician
gener
would
rather
overtreat
miss
potenti
curabl
condit
clearli
logic
justifi
stanc
consid
individu
patient
two
broad
consequ
first
especi
hospit
increas
evolutionari
pressur
emerg
antibioticresist
pathogen
time
lack
new
antibiot
well
recogn
second
consequ
low
threshold
fals
posit
true
noninfect
caus
patient
present
often
remain
undiagnos
remain
way
short
optim
situat
accur
diagnost
give
suffici
high
sensit
specif
target
antibiot
patient
requir
clinic
acumen
radiolog
microbiolog
sampl
limit
care
consider
three
togeth
allow
reliabl
diagnosi
cap
much
time
level
diagnost
confid
lower
consid
hapvap
histori
breathless
product
cough
fever
fatigu
pleurit
chest
pain
evolv
day
along
sign
tachypnoea
bronchial
breath
whisper
pectoriloquy
make
diagnosi
probabl
pneumonia
easi
diagnost
confid
confirm
compat
cxr
howev
constel
featur
rare
occur
patient
pneumonia
cough
breathless
mani
sputum
product
histori
must
consid
context
background
level
function
immun
compet
comorbid
copd
diabet
mellitu
renal
impair
liver
diseas
chronic
heart
diseas
malign
immunosuppress
medic
predispos
pneumonia
histori
includ
question
smoke
alcohol
consumpt
k
pneumonia
associ
alcohol
depend
foreign
travel
l
pneumophila
return
area
particular
pneumonia
endem
enquiri
also
made
recent
flulik
symptom
relev
contact
pneumonia
aureu
h
influenza
even
primari
influenza
pneumonia
may
caus
pneumonia
influenza
season
occup
contact
anim
avian
exposur
suggest
possibl
psittacin
pneumonia
gener
zoonos
rare
sexual
substanc
histori
also
import
hiv
test
consid
patient
pneumonia
histori
dysphagia
choke
also
relev
featur
clearli
associ
increas
risk
pneumonia
particularli
right
lower
lobe
middl
lobe
pneumonia
myalgia
diarrhoea
headach
may
alert
clinician
possibl
legionnair
diseas
patient
moder
sever
pneumonia
abdomin
pain
obvious
deserv
full
attent
right
occasion
repres
refer
pain
diaphragmat
pleurisi
addit
physic
sign
chest
examin
previous
describ
signific
dental
decay
suggest
oral
pathogen
especi
anaerob
obtain
haematogen
rout
gum
lung
frail
elderli
patient
impair
swallow
rais
possibl
repeat
aspir
histori
examin
rare
conclus
radiolog
crucial
air
bronchogram
wellcentr
posteroanterior
cxr
deep
inspir
pathognomon
rare
achiev
slump
frail
elderli
situat
magnifi
context
suspect
hap
icu
cxr
semirecumb
patient
notori
hard
interpret
well
recognis
even
goodqual
cxr
often
miss
consolid
may
detect
comput
tomographi
ct
scan
microbiolog
sampl
crucial
import
diagnosi
pneumonia
guid
treatment
appropri
clinic
context
gram
stain
highqual
sputum
sampl
reveal
exampl
string
gramposit
cocci
consist
pneumonia
would
confirm
diagnosi
guid
treatment
rare
possibl
three
main
problem
consid
relat
microbiolog
sampl
respiratori
tract
first
mani
patient
pneumonia
sputum
product
secondli
patient
commonli
alreadi
take
empir
antibiot
present
hospit
recognis
sputum
cultur
less
like
give
accur
reflect
pneumonia
set
thirdli
pneumonia
infect
alveolar
region
lung
often
hard
certain
sampl
deriv
relev
part
respiratori
tract
context
cap
main
challeng
disregard
contamin
colonis
bacteria
upper
respiratori
tract
gener
howev
goodqual
expector
sputum
sampl
consid
repres
alveolar
patholog
patient
cap
unfortun
situat
hap
vap
starkli
differ
suspect
hap
highqual
sputum
product
patient
rare
occurr
clearli
diagnost
cxr
set
empir
antibiot
usual
given
suspect
hap
notori
poorli
studi
conserv
estim
altern
diagnosi
pneumonia
like
present
patient
suspect
vap
present
uniqu
differ
set
circumst
patient
alreadi
critic
ill
addit
burden
pneumonia
seem
confer
appreci
attribut
mortal
risk
miss
pneumonia
add
pressur
prescrib
empir
antibiot
studi
consist
show
true
pneumonia
present
around
onethird
patient
suspect
vap
mucu
product
conduct
airway
markedli
increas
mechan
ventil
patient
tracheal
aspir
poorli
reflect
alveolar
patholog
contribut
significantli
fals
posit
diagnos
pneumonia
unlik
case
cap
hap
clinician
potenti
access
alveolar
space
bronchoscopi
bronchoalveolar
lavag
bal
perform
control
circumst
via
endotrach
tube
highqual
bal
specif
sampl
relev
region
clinician
must
choos
empir
treatment
knowledg
correct
diagnosi
may
vap
twothird
case
invas
diagnost
procedur
one
larg
randomis
control
trial
rct
suggest
better
outcom
bronchoscop
approach
anoth
show
differ
argu
imagedirect
bronchoscop
bal
cultur
coloni
form
unitsml
strongli
suggest
vap
blood
cultur
strongli
recommend
patient
suspect
moder
sever
pneumonia
particularli
patient
febril
similarli
worthwhil
cultur
pleural
fluid
easili
quickli
safe
obtain
plethora
antigen
molecular
test
becom
avail
exquisit
sensit
pcrbase
test
increas
absolut
requir
highqual
sampl
perform
microbiolog
clearli
predomin
organ
highqual
sampl
greatli
increas
likelihood
respons
pathogen
lowlevel
identif
multipl
organ
lowqual
sampl
like
indic
contamin
colonis
concern
increasingli
sensit
test
use
judici
may
exacerb
problem
overprescript
antibiot
caphapaspirationimmunocompromis
host
classif
ensur
better
empir
antibiot
select
pneumonia
gener
parallel
manag
improv
introduct
prognost
risk
stratif
score
applic
cap
commonli
use
pneumonia
sever
index
score
score
tabl
simpl
use
deriv
uk
cohort
guidelin
propos
patient
cap
score
manag
home
score
manag
hospit
score
prompt
consider
higher
level
care
exampl
icu
three
import
caveat
must
note
first
score
must
replac
clinic
judgment
provid
prognost
estim
wide
confid
interv
clinic
judgment
experi
alway
trump
view
support
guid
second
caveat
around
tool
appli
singl
point
time
usual
present
yet
deterior
occur
rapidli
third
caveat
perform
less
well
predict
patient
requir
manag
intens
care
environ
emphasis
primari
role
clinic
judgment
assess
prognosi
patient
cap
patient
discharg
hospit
mild
pneumonia
gener
practition
district
nurs
abl
confirm
appropri
progress
ensu
period
set
hospit
ward
monitor
progress
detect
clinic
deterior
develop
complic
mainstay
treatment
pneumonia
divid
gener
measur
antibiot
therapi
patient
often
hypoxaem
optim
level
pao
improv
outcom
pneumonia
undefin
supplement
oxygen
gener
use
maintain
pao
kpa
oxygen
satur
maintain
insens
fluid
loss
often
underestim
requir
correct
system
inflammatori
process
pneumonia
gener
promot
venou
thrombu
format
compound
immobl
patient
thromboprophylaxi
unless
specif
contraind
mobilis
bed
quickli
feasibl
confus
abbrevi
mental
test
score
less
new
disorient
person
place
time
blood
urea
mmoll
respiratori
rate
breath
per
minut
low
blood
pressur
diastol
mmhg
less
systol
less
mmhg
age
year
score
calcul
give
point
prognost
featur
pneumonia
induc
signific
catabol
effect
multifactori
probabl
respons
system
upset
muscl
wast
physiotherapi
dietet
input
import
maintain
muscl
tone
independ
mobil
increas
calorif
intak
antiemet
obvious
help
allow
better
calorif
intak
profound
fatigu
pneumonia
persist
week
month
otherwis
full
recoveri
pleurisi
accompani
case
pneumonia
treat
analges
opioid
may
requir
reliev
pain
allow
effect
aerat
affect
side
evid
use
antituss
patient
pneumonia
fail
respond
appar
good
treatment
like
explan
diagnosi
pneumonia
incorrect
underli
medic
condit
predispos
pneumonia
dictat
tempo
ill
failur
respond
lead
consider
complic
empyema
possibl
particularli
hapvap
aspir
sever
cap
includ
inadequ
inappropri
antibiot
coverag
respons
pathogen
involv
antibioticresist
organ
discharg
patient
must
follow
pneumonia
occasion
first
declar
tumour
occlud
bronchu
repeat
cxr
week
gener
advis
particularli
smoker
patient
age
complet
radiograph
resolut
agedepend
lag
well
behind
clinic
improv
cxr
improv
week
failur
resolut
prompt
investig
usual
ct
first
instanc
consensu
treatment
uk
patient
adequ
social
circumst
safe
oral
intak
medic
allergi
outsid
influenza
pandem
follow
score
manag
home
oral
amoxicillin
score
manag
hospit
ward
oral
amoxicillin
oral
clarithromycin
low
appreci
risk
l
pneumophila
respons
score
manag
hospit
consid
manag
critic
care
area
icu
keep
mind
less
effect
predict
patient
requir
critic
care
pragmat
approach
combin
clinic
judgment
arteri
blood
ga
result
advis
term
antibiot
combin
intraven
coamoxiclav
clarithromycin
use
l
pneumophila
strongli
suspect
addit
cover
consid
eg
use
levofloxacin
known
flu
pandem
andor
patient
flulik
symptom
preced
pneumonia
consid
ad
intraven
flucloxacillin
cover
aureu
exact
choic
antibiot
particularli
drug
allergi
present
best
guid
discuss
hospit
microbiologist
consult
recent
updat
british
thorac
societi
nice
websit
guidelin
gener
recommend
patient
hospitalis
cap
particularli
score
receiv
antibiot
within
h
clinic
suspicion
basi
evid
delay
antibiot
associ
higher
mortal
emphasis
observ
cap
diagnost
sampl
delay
prescrib
gener
clinic
assess
cxr
compat
cap
antibiot
medic
prescrib
prepar
administr
attempt
made
obtain
blood
cultur
sputum
cultur
includ
legionella
cultur
pcr
cover
atyp
pathogen
respiratori
virus
appropri
ultrasoundguid
pleural
aspir
appropri
urin
obtain
pneumococc
legionella
antigen
test
use
rule
test
blood
sent
serolog
test
atyp
pathogen
viral
patholog
particularli
expect
durat
antibiot
requir
uncompl
cap
subject
consider
debat
gener
trend
pneumonia
care
shorter
cours
antibiot
recent
nice
guidelin
recommend
day
mild
cap
manag
commun
day
moder
sever
cap
treatment
may
extend
accord
clinic
judgement
particularli
aureu
gramneg
enter
bacilli
confirm
longer
antibiot
cours
often
requir
complic
empyema
abscess
ensu
one
particular
controversi
continu
aris
whether
antibiot
recommend
uk
guidelin
increas
risk
clostridium
difficil
coliti
divid
opinion
significantli
mani
hospit
adjust
cap
guidelin
recommend
antibiot
less
commonli
associ
c
difficil
current
seem
reason
appli
nation
guidelin
unless
local
microbiolog
epidemiolog
suggest
clear
associ
antibiot
question
c
difficil
coliti
interest
develop
use
blood
creactiv
protein
crp
concentr
monitor
respons
therapi
patient
moder
sever
pneumonia
gener
recognis
crp
fall
day
adequ
antibiot
therapi
explan
lack
respons
sought
nice
guidelin
also
made
recommend
antibiot
initi
base
crp
patient
commun
suspect
lower
respiratori
tract
infect
antibiot
offer
crp
mgl
delay
cours
given
crp
mgl
symptom
worsen
antibiot
initi
crp
concentr
mgl
guidelin
manag
vap
hap
gener
advis
antibiot
therapi
dictat
sever
patient
ill
likelihood
multidrug
resist
pathogen
time
spent
hospit
time
write
updat
european
guidelin
vap
pend
broad
amalgam
interpret
variou
guidelin
would
suggest
patient
vap
intens
care
unit
day
consid
high
risk
multidrug
resist
pathogen
tabl
sever
unwel
exampl
evid
sever
sepsi
monotherapi
limitedspectrum
antibiot
eg
coamoxiclav
approxim
day
seem
appropri
guidelin
take
slightli
differ
view
manag
patient
hospit
day
andor
risk
multidrug
resist
mdr
pathogen
andor
sever
unwel
howev
organ
confid
isol
gener
consensu
use
singl
antibiot
fulli
sensit
around
day
organ
isol
north
american
view
gener
give
two
antibiot
differ
mode
action
aim
cover
rang
gramneg
pathogen
importantli
p
aeruginosa
pneumonia
mssa
addit
cover
mrsa
known
preval
icu
question
uk
guidelin
give
lessspecif
advic
favour
monotherapi
possibl
make
use
local
microbiolog
epidemiolog
treatment
recommend
approxim
day
figur
day
base
trial
compar
versu
day
treatment
found
differ
outcom
interestingli
recent
paper
suggest
adher
previou
american
thorac
societi
infecti
diseas
societi
america
guidelin
empir
treatment
vap
patient
risk
mdr
pathogen
associ
increas
mortal
precis
interpret
find
difficult
one
tent
suggest
would
seek
pathogen
wherev
possibl
hope
reduc
antibiot
load
guidelin
gener
recommend
possibl
respiratori
sampl
obtain
vap
suspect
empir
antibiot
start
immedi
afterward
accord
publish
guidelin
standard
cultur
typic
day
later
suggest
respons
organ
antibiot
deescal
rationalis
stage
goodqual
cultur
return
growth
patient
deterior
antibiot
potenti
withdrawn
approach
seem
sensibl
clinic
often
prove
challeng
clearli
approach
irrelev
patient
respiratori
sampl
obtain
patient
ongo
extrapulmonari
indic
antibiot
centr
seek
improv
antibiot
stewardship
consid
earli
withdraw
antibiot
procalcitonin
level
clearli
decreas
parallel
clinic
improv
clinic
pulmonari
infect
score
rel
cumbersom
score
system
rang
remain
day
empir
treatment
urgenc
antibiot
prescript
vap
also
less
clearcut
cap
delay
prescript
appropri
antibiot
associ
increas
mortal
vap
evid
increas
mortal
begin
h
clinic
suspicion
vap
weak
nevertheless
vap
suspect
seem
emin
sensibl
obtain
goodqual
bal
sampl
within
next
h
possibl
start
empir
monotherapi
immedi
refin
antibiot
base
clinic
cours
cultur
result
hap
true
preval
microbiolog
aetiolog
optim
manag
strategi
aspir
pneumonia
hard
defin
microbiolog
aspir
pneumonia
gradual
shift
predominantli
diseas
caus
anaerob
bacteria
one
akin
earli
hap
perhap
overrepresent
gramneg
bacilli
longerterm
resid
nurs
home
p
aeruginosa
may
complic
aspir
pneumonia
seem
reason
treat
patient
high
likelihood
aspir
pneumonia
admit
home
though
cap
earli
hap
l
pneumophila
implic
seem
reason
treat
patient
coamoxiclav
guid
local
microbiolog
epidemiolog
low
threshold
broaden
gramneg
cover
deterior
patient
admit
nurs
home
hospit
facil
may
advis
give
gramneg
cover
either
cephalosporin
nurs
home
hospit
resid
longterm
antipseudomon
antibiot
smoke
cessat
influenza
vaccin
pneumococc
vaccin
appear
reduc
risk
pneumonia
suscept
popul
tabl
evid
base
measur
prevent
vap
vast
persuas
evid
gener
infect
control
measur
like
good
hand
hygien
reduc
incid
nosocomi
infect
probabl
extend
vap
risk
factor
vap
well
describ
form
basi
plethora
prevent
strategi
biggest
risk
factor
vap
intub
inappropri
use
antibiot
although
avoid
either
may
imposs
effect
prevent
measur
appear
includ
manag
patient
semirecumb
rather
supin
posit
daili
interrupt
sedat
prelud
wean
subglott
drainag
controversi
continu
whether
oral
chlorhexidin
select
digest
decontamin
advantag
prevent
strategi
endless
way
manag
prevent
pneumonia
could
improv
conclud
chapter
shall
consid
four
import
aim
difficult
achiev
success
could
make
major
differ
outcom
first
obvious
gener
novel
way
erad
pathogen
effici
without
toxic
host
dearth
new
antibiot
emerg
use
clinic
practic
well
document
though
intens
research
continu
new
way
disrupt
key
bacteri
surviv
mechan
context
increas
interest
focus
way
boost
host
innat
immun
mechan
clear
bacteri
pathogen
may
begin
suggest
novel
nonantibioticbas
approach
improv
diagnost
accuraci
pneumonia
clearli
also
present
challeng
futur
particularli
true
elderli
hospitalis
patient
given
frailti
extens
comorbid
broaden
differenti
diagnosi
consider
impair
diagnost
precis
cxr
reduc
realist
chanc
obtain
microbiolog
sampl
repres
alveolar
space
ideal
scenario
gener
annual
annual
rapid
nearpati
blood
test
discrimin
pneumonia
caus
lung
inflamm
remain
distant
aspir
much
activ
interest
find
truli
diagnost
biomark
also
consider
interest
obtain
microbiolog
diagnos
lessinvas
specimen
caution
need
exercis
explos
interest
microbiom
whole
genom
sequenc
pathogen
fundament
reposit
understand
normal
diseaseassoci
microbiom
deep
lung
howev
relationship
detail
molecular
microbiolog
pneumonia
effect
chang
manag
far
work
one
concern
extrem
sensit
molecular
diagnost
may
lead
detect
harmless
commens
misinterpret
pathogen
turn
lead
overus
antibiot
third
area
interest
attract
increas
interest
particularli
sepsi
research
contribut
host
innat
respons
outcom
sever
infect
intrigu
bodi
literatur
suggest
overact
underact
innat
immun
respons
seriou
infect
noninfect
insult
may
dictat
clinic
outcom
greater
extent
infect
prolong
state
rel
immunosuppress
respons
sepsi
may
particularli
import
regard
improv
understand
innat
immun
respons
pneumonia
requir
earli
indic
suggest
identif
key
pathway
regul
magnitud
innat
immun
respons
may
provid
target
therapeut
intervent
previou
area
highlight
would
major
implic
improv
pneumonia
care
healthcar
system
uk
far
greater
challeng
face
medicin
har
suffici
polit
organis
clinic
infrastructur
address
appal
ongo
incid
pneumonia
particularli
extrem
life
develop
countri
